← All trials
NCT05348694
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 31, 2022
- Primary completion
- May 31, 2024
- Completion date
- May 31, 2025
- First posted
- Apr 27, 2022
- Last posted
- Apr 27, 2022
- Enrollment
- 160
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Australian Catholic UniversityLead sponsor
- Curtin UniversityCollaborator
- Pendulum TherapeuticsCollaborator
- Australian Catholic UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.